http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0429984-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 1990-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0429984-A3
titleOfInvention Indole derivatives
abstract Disclosed are compounds of formula I <CHEM> wherein R1 is a hydrogen atom, a C1-C6 alkyl group, benzyl or an indolyl carbonyl group, R2 is a saturated or unsaturated 5- or 8-membered heterocyclic group containing as a hetero atom one or more nitrogen atoms, the heterocyclic group is optionally substituted at an N or C atom by a C1-C6 alkyl or aralkyl group, n is an integer of 1 to 5 and one or more hydrogen atoms, in an alkylene chain -(CH2)n- are optionally substituted by a C1-C6 alkyl, phenyl and/or hydroxyl group, physiologically acceptable salts and quaternary ammonium salts thereof. The compounds are selective antagonists of 5-HT3 receptors and are useful in the treatment of psychotic disorders, neurotic diseases, gastric stasis symptoms, gastrointestinal disorders, nausea and vomiting.
priorityDate 1989-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0144986-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8400166-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0347229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0307145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8502847-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798

Total number of triples: 22.